METTL14 and hepatocellular carcinoma: METTL14 also promotes the stability of HNF3γ mRNA through IGF2BPs-dependent m6A modification, resulting in the upregulation of HNF3γ expression, which has been shown to play an important role in HCC stem cells differentiation and in regulating the sensitivity of HCC cells to sorafenib treatment [14].